The Institutional Insight program educates clinicians, patients and their caregivers on the latest advances and treatments in multiple myeloma.
For Patients and Caregivers
MMRF Institutional Insights is an exciting program created specifically for
patients, caregivers, and their family and friends to learn more about
multiple myeloma and today's most promising treatment options, including
clinical trials, from leading multiple myeloma doctors and researchers.
The MMRF conducts these physician and patient symposia at top myeloma cancer
centers across the country.
The MMRF conducts these physician and patient symposia at top myeloma cancer centers across the country.
To register for an Institutional Insights Clinician or Patient Program, please select an event below.
For Clinicians and Healthcare Professionals
The MMRF developed Institutional Insights, a CME symposia series that brings myeloma experts into select cancer centers in the United States. Each symposium features internationally recognized myeloma experts who distill data from the most recent major medical meetings.
Who should attend:
These activities have been designed to meet the educational needs of
- Hematologists
- Medical Oncologists
- Oncology Nurses
- Internists with recently diagnosed patients
Educational Objectives:
At the conclusion of these activities, the participants should be able to:
- Identify the prognostic indicators and diagnostic approaches to multiple myeloma.
- Discuss the latest advances in stem cell transplantation, treatments for bone disease, and supportive care management.
- Describe the role and appropriate use of novel treatments for multiple myeloma throughout the disease progression.
Institutional Insights in Multiple Myeloma, provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease, and supportive care.
Upcoming Seminars (click program link for details and registration):
| Topics: | |
| Frontline Therapy |
Stem Cell Transplant |
| Relapsed/Refractory Disease |
Supportive Care |
| Clinical Trials |
Question & Answer |
-
July 23, 2009 – Boston, MA
Institutional Insights in Multiple Myeloma
-
Patient Program
Thursday, June 18, 2009 – Chicago, IL
Institutional Insights in Multiple Myeloma
Institutional Insights in Multiple Myeloma provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease and supportive care. Our panel of experts will discuss case studies as they apply to the topics.
Patient & Caregiver Program
Multiple myeloma patients and caregivers are encouraged to attend this program. Attendees will learn about the latest findings in research and treatment of multiple myeloma from the leading myeloma experts.
Patient Program
Thursday, June 18th
11:00 AM – 2:00 PM
Location:
Hilton Chicago
720 S. Michigan Avenue
Chicago, IL (
directions)
Agenda:
10:30 AM – 11:00 AM
Registration |
11:00 AM – 2:00 PM
Program |
Detailed Agenda:
Frontline Therapy
Dr. Andrzej Jakubowiak
University of Michigan Comprehensive Cancer Center |
Stem Cell Transplantation
Dr. David Vesole
Loyola University Medical Center |
Therapies for Relapsed/Refractory Disease
Dr. Donna Reece
Princess Margaret Hospital |
Bone Disease and Supportive Care
Dr. Craig Hofmeister
Ohio State University Medical Center |
Clinical Trials
Dr. Todd Zimmerman
University of Chicago Medical Center |
Panel Q & A
|
Thursday, July 23, 2009 – Boston, MA
Institutional Insights in Multiple Myeloma provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease and supportive care. Our panel of experts will discuss case studies as they apply to the topics.
Patient & Caregiver Program
Multiple myeloma patients and caregivers are encouraged to attend this program. Attendees will learn about the latest findings in research and treatment of multiple myeloma from the leading myeloma experts.
Patient Program
Thursday, July 23rd
11:00 AM – 2:00 PM
Location:
The Westin Copley Place
10 Huntington Avenue
Boston, MA 02116 (
directions)
Program Chairs:
Paul Richardson, MD
Ken Anderson, MD
Dana-Farber Cancer Center
Associate Professor of Medicine
Agenda:
10:30 AM – 11:00 AM
Registration |
11:00 AM – 2:00 PM
Program |
Detailed Agenda:
10:30 AM — 11:00 AM
Registration
MMRF
|
11:00 AM — 11:10 AM
Welcome
MMRF
|
11:10 AM — 11:35 AM
Frontline Therapy
Sundar Jagannath
St. Vincent's |
11:35 AM — 12:00 PM
Transplant
Sergio Giralt, MD
MD Anderson |
12:00 PM — 12:25 PM
Relapsed/Refractory Disease
Paul Richardson, MD
|
12:25 PM — 12:40 PM
Break for Lunch
Lunch will be provided
|
12:40 PM — 1:05 PM
Supportive Care
Todd Zimmerman, MD
University of Chicago |
1:05 PM — 1:30 PM
Clinical Trials
Ken Anderson, MD
|
1:30 PM — 2:00 PM
Question & Answer
Faculty
|
2:00 PM
Evaluation & Adjourn
|
Friday, April 4, 2008 – Los Angeles
Institutional Insights in Multiple Myeloma provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease and supportive care. Our panel of experts will discuss case studies as they apply to the topics.
Patient & Caregiver Program
Multiple myeloma patients and caregivers are encouraged to attend this program. Attendees will learn about the latest findings in research and treatment of multiple myeloma from the leading myeloma experts.
Patient Program
Friday, April 4th
8:30 AM – 12:00 PM
Hilton Pasadena
168 South Los Robles Avenue
Pasadena, California (
directions)
Program Chair:
Amrita Krishnan, MD
City of Hope Comprehensive Cancer Center
Associate Professor & Physician, Department of Hematology and Hematopoietic Cell Transplantation;
Associate Director, Medical Education and Training, Division of Hematology and Hematopoietic Cell Transplantation Member
Detailed Agenda:
9:00am – 9:30am — Registration
|
9:30 – 9:40 — Welcome & Introduction
MMRF
|
9:40 – 10:20 — Frontline Therapy/Supportive Care
Keith Stewart, MD
Mayo Clinic |
10:20 – 11:00 — Transplant
Amrita Krishnan, MD
City of Hope |
11:00 – 11:10 — Break
|
11:10 – 11:50 — Relapsed/Refractory Disease/Clinical Trials
Robert Vescio, MD
Cedars–Sinai Medical Center |
11:50 – 12:15 — Panel Q & A
Panel |
12:15 — Evaluation & Adjourn
|
Friday, September 5, 2008 – Atlanta, GA
Institutional Insights in Multiple Myeloma
Institutional Insights in Multiple Myeloma provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease and supportive care. Our panel of experts will discuss case studies as they apply to the topics.
Clinician Program
Friday, September 5th
J.W. Marriott Buckhead Atlanta
3300 Lenox Road NE
Atlanta, GA
Program Chair:
Sagar Lonial, MD
The Emory Clinic
Assistant Professor of Hematology and Oncology
Director, Translational Research B-cell Malignancy Program
Agenda:
Detailed Agenda:
Friday, September 5, 2008 &ndash Atlanta
Institutional Insights in Multiple Myeloma provides practical insight on how to apply the latest advances in diagnosis, prognosis, frontline therapy, treatments for relapsed/refractory disease, management of bone disease and supportive care. Our panel of experts will discuss case studies as they apply to the topics.
Patient & Caregiver Program
Multiple myeloma patients and caregivers are encouraged to attend this program. Attendees will learn about the latest findings in research and treatment of multiple myeloma from the leading myeloma experts.
Patient Program
Friday, September 5th
11:00 AM – 2:00 PM
JW Marriott Buckhead
3300 Lenox Road NE
Atlanta, GA 30326
404.262.3344
www.jwmarriottbuckhead.com
Program Chair:
Sagar Lonial, MD
The Emory Clinic
Assistant Professor of Hematology and Oncology
Director, Translational Research B-cell Malignancy Program
Patient Agenda:
Registration — 10:30am – 11:00am
Program — 11:00am – 2:00pm
Detailed Agenda:
Registration
|
Welcome & Introduction
|
Frontline Therapy
|
Transplant
|
Relapsed/Refractory Disease
|
Supportive Care
|
Clinical Trials
|
Panel Q & A
|
Evaluation & Adjourn
|
American Institute of Philanthropy
Charity Navigator
Best in America Seal
